A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

October 29, 2024

Study Completion Date

November 14, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

IP

NX-5948 oral

DRUG

Matching Placebo

Fluconazole

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Nurix Therapeutics, Inc.

INDUSTRY

NCT06593457 - A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter